human
infect
newli
reassort
avian
influenza
viru
report
first
time
earli
viru
confirm
low
pathogen
avian
influenza
viru
poultri
continu
report
case
increas
sinc
summer
novel
viru
pose
potenti
threat
public
health
china
attract
broad
attent
worldwid
review
summar
discuss
characterist
viru
reveal
recent
time
studi
perspect
epidemiolog
host
prefer
clinic
manifest
immunopathogenesi
drug
resist
vaccin
develop
burden
diseas
knowledg
novel
avianorigin
viru
provid
use
refer
clinic
intervent
human
infect
help
rapidli
pave
way
develop
effici
safe
vaccin
case
laboratoryconfirm
human
infect
avianorigin
influenza
viru
yangtz
river
delta
region
china
date
back
februari
subsequ
two
month
number
laboratoryconfirm
infect
soon
grew
appar
case
fatal
rate
case
occur
addit
locat
throughout
china
patient
histori
recent
exposur
poultri
gener
live
poultri
market
lpm
suggest
direct
transmiss
viru
poultri
human
human
infect
continu
report
viru
could
detect
lpm
flu
season
viru
still
pose
threat
public
health
direct
transmiss
avian
influenza
virus
domest
poultri
human
document
subtyp
gener
low
pathogen
avian
influenza
virus
lpaiv
usual
associ
mild
diseas
poultri
report
human
infect
lpaiv
caus
upper
respiratori
tract
ill
vari
mild
conjunct
uncompl
influenzalik
ill
moder
sever
wherea
highli
pathogen
avian
influenza
virus
hpaiv
caus
sever
ill
high
mortal
poultri
human
infect
hpaiv
result
conjunct
uncompl
influenza
ill
except
subtyp
associ
mortal
subtyp
caus
one
death
outbreak
netherland
recent
outbreak
repres
first
time
ever
lpaiv
infect
human
caus
diseas
herein
review
characterist
novel
avian
influenza
viru
diseas
caus
perspect
epidemiolog
clinic
featur
immunolog
receptor
bind
drug
resist
vaccin
develop
virolog
surveil
phylogenet
analys
confirm
transmiss
infect
poultri
human
figur
direct
evid
reveal
infect
case
jiangsu
provinc
china
femal
butcher
infect
phylogenet
relat
viru
isol
chicken
cage
away
thu
urgent
call
control
exposur
poultri
farm
lpm
mani
lpm
still
open
reopen
short
closur
recent
ecolog
studi
assur
effect
closur
lpm
sinc
april
novel
virus
appear
reassort
segment
least
four
differ
origin
hemagglutinin
ha
gene
duck
virus
neuraminidas
na
gene
wild
bird
korea
intern
gene
two
distinct
lineag
poultri
virus
recent
work
demonstr
within
first
influenza
infect
wave
total
genotyp
observ
divers
intern
gene
vari
lineag
conserv
ha
na
gene
virus
origin
poultri
genet
reassort
surpris
viru
could
easili
reassort
poultri
virus
figur
current
studi
suggest
none
viru
genotyp
gain
overwhelm
fit
advantag
still
undergo
dynam
reassort
within
poultri
gene
pool
whether
super
reassort
fit
mammalian
host
would
appear
unpredict
genet
reassort
often
major
effect
influenza
viru
replic
within
cell
therefor
extens
surveil
control
poultri
product
transport
urgent
prioriti
clinic
characterist
human
lpaiv
viru
infect
somewhat
compar
infect
hpaiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
acut
infect
caus
sever
ill
respiratori
failur
acut
respiratori
distress
syndrom
ard
high
rate
icu
admiss
multivari
analys
reveal
presenc
underli
medic
condit
independ
risk
factor
ard
togeth
exist
mildtomoder
infect
case
detect
china
nation
sentinel
surveil
system
influenzalik
ill
viru
infect
seem
less
seriou
initi
thought
begin
outbreak
similar
observ
infect
immunopathogenet
analysi
infect
sampl
reveal
high
level
plasma
proinflammatori
cytokin
chemokin
term
hypercytokinemia
earli
stage
infect
concentr
sever
cytokineschemokin
includ
even
higher
previous
report
infect
case
furthermor
hypercytokinemia
correl
diseas
sever
infect
higher
level
detect
fatal
case
compar
survivor
infect
data
indic
plasma
level
angiotensin
ii
correl
diseas
sever
predict
fatal
outcom
patient
recent
studi
elucid
human
singl
nucleotid
polymorph
snp
associ
dysfunct
interferon
induc
transmembran
play
crucial
genet
role
earli
hypercytokinemia
develop
patient
despit
progress
remain
import
profil
sequenti
connect
cytokineschemokin
clarifi
key
factor
infect
process
particularli
local
mucos
tissu
lung
patient
patient
display
robust
serolog
respons
onset
diseas
reveal
antibodi
reactiv
kinet
detect
antibodi
appear
sera
survivor
earlier
fatal
case
addit
highest
antibodi
titer
fatal
case
also
lower
survivor
among
emerg
virus
survivor
infect
group
higher
antibodi
titer
experi
shorter
time
onset
diseas
recoveri
data
indic
earlier
robust
humor
respons
provid
protect
effect
improv
clinic
outcom
patient
data
tcell
respons
patient
still
lack
howev
immunoinformat
analysi
protein
indic
conserv
tcell
epitop
recent
circul
strain
influenza
limit
approxim
previous
welldefin
major
histocompat
complex
class
mhc
restrict
tcell
epitop
substitut
correspond
sequenc
reveal
comparison
figur
furthermor
studi
human
leukocyt
antigen
hla
type
healthi
subject
demonstr
season
influenza
virusspecif
tcell
poorli
crossreact
individu
variant
epitop
apart
recognit
whole
viru
also
indic
tcell
immun
influenza
viru
vari
across
differ
ethnic
group
base
hla
background
thu
investig
featur
tcell
respons
patient
comparison
tcellrel
immunogen
varianc
current
circul
influenza
virus
exampl
perform
influenza
virus
enter
host
cell
endocytosi
bind
cellsurfac
receptor
sialic
acid
sa
link
cellsurfac
glycolipid
glycoprotein
sabind
protein
ha
major
determin
viru
host
jump
known
three
secondari
element
one
base
element
ha
receptor
bind
pocket
directli
involv
sa
bind
shallow
receptor
bind
caviti
three
secondari
element
form
edg
number
respect
base
element
mainli
compos
four
conserv
residu
molecular
base
receptor
bind
shift
explor
sever
studi
differ
group
includ
elucid
basi
aviantohuman
host
jump
influenza
viru
begin
outbreak
virus
two
earliest
strain
preferenti
bind
avian
receptor
analog
wherea
recogn
avian
human
receptor
analog
contrast
influenza
humansignatur
substitut
sole
respons
bind
influenza
viru
ha
human
receptor
rather
amino
acid
around
receptor
bind
site
rb
also
import
four
residu
rb
differ
abl
creat
larger
hydrophob
region
left
side
rb
allow
easili
bind
human
receptor
analog
avail
fluspecif
antiviru
drug
appli
clinic
treatment
mainli
focu
two
influenza
protein
firstli
target
amantadinerimantadin
final
na
target
four
type
inhibitor
oseltamivir
zanamivir
peramivir
laninamivir
protein
deriv
report
contain
substitut
indic
resist
amantadinerimantadin
target
na
inhibitor
commonli
use
clinic
effect
drug
influenza
howev
viru
strain
also
contain
substitut
na
associ
drug
resist
rais
seriou
concern
residu
one
three
key
arginin
activ
site
two
directli
interact
substrateinhibitor
carboxyl
decreas
interact
inhibitor
carboxyl
group
play
essenti
role
reduc
drug
sensit
figur
furthermor
effect
rotat
side
chain
unfavor
posit
accommod
oseltamivir
hydrophob
pentyloxi
group
therebi
significantli
reduc
oseltamivir
sensit
howev
vitro
assay
demonstr
impair
na
activ
advantag
viru
replic
good
news
treatment
patient
sever
differ
approach
includ
use
live
recombin
viral
vectorbas
vaccin
live
attenu
influenza
vaccin
univers
dna
vaccin
viruslik
particl
vlp
explor
meet
urgent
challeng
vaccin
develop
combat
infect
one
vaccin
contain
recombin
newcastl
diseas
viru
express
ha
two
live
attenu
vaccin
investig
crossreact
viru
may
subsequ
univers
dna
vaccin
base
antibodi
target
ha
stalk
region
examin
possibl
candid
prevent
infect
stalkbas
vaccin
abl
elicit
antibodi
reactiv
protein
also
protect
mice
challeng
addit
insect
cellderiv
vlp
contain
ha
na
display
promis
protect
mice
inde
shortli
anim
experi
enrol
adult
initi
phase
clinic
trial
monoval
vlp
vaccin
candid
without
adjuv
clinic
trial
suggest
vlp
presenc
adjuv
induc
immun
respons
low
dosag
recent
data
also
indic
antigen
prepar
diverg
strain
abl
induc
protect
immun
infect
effort
develop
effect
influenza
vaccin
tradit
new
techniqu
attempt
shorten
product
cycl
meet
manufactur
requir
rapid
deploy
outbreak
infect
mainland
well
taiwan
hong
kong
china
pose
great
burden
societi
basi
recent
data
total
direct
medic
cost
may
lpm
close
poultri
cull
area
compar
poultryindustri
loss
direct
medic
loss
dali
loss
rel
small
closur
lpm
reduc
mean
daili
number
infect
shanghai
hangzhou
huzhou
nanj
base
bayesian
statist
model
time
seri
onset
ill
howev
medic
cost
per
case
extrem
high
particularli
address
use
modern
medic
devic
costeffect
assess
diseas
intervent
yet
determin
outbreak
lpaiv
viru
earli
gener
tremend
concern
recent
studi
reveal
novel
properti
viru
epidem
genet
analysi
illustr
novel
reassort
event
appar
facilit
transmiss
poultri
human
call
host
jump
facilit
unconvent
featur
ha
receptor
bind
pocket
preliminari
understand
clinic
manifest
immunopathogenet
properti
infect
indic
complic
interact
viru
host
knowledg
gain
regard
novel
avian
viru
may
help
pave
way
rapidli
conquer
includ
approach
develop
effici
safe
vaccin
howev
consid
continu
unexpect
emerg
human
infect
novel
avian
influenza
virus
exampl
necessari
devot
attent
surveil
interspeci
transmiss
influenza
virus
toward
develop
univers
vaccin
studi
evalu
predict
valu
angiotensin
ii
diseas
sever
fatal
outcom
patient
indic
angiotensin
ii
biomark
lethal
flu
infect
